Biotech Archives | the deep dive

Sona Nanotech Halts COVID-19 Rapid Saliva Test Trials, Drops Research Program

Sona Nanotech (CSE: SONA) this morning had bombshell news, in that it has discontinued its clinical trial for a COVID-19

BriaCell Therapeutics Corp. (TSXV: BCT) announced today that they have received gross proceeds from exercised warrants amounting to US$12.9 million.

This morning Biogen (NASDAQ:BIIB) received approval from the FDA for their Alzheimer’s drug aducanumab. The FDA decision marks the first

Bright Minds Biosciences Inc. (CSE: DRUG) is a small-cap preclinical biosciences company that is attempting to create the next generation of

It appears that Cronos Group (TSX: CRON) (NASDAQ: CRON) might be losing its star player. Ginkgo Bioworks this morning announced

MustGrow Biologics (CSE: MGRO) is progressing with field trials for its TerraMG product. The company announced this morning that it

InMed Pharmaceuticals Inc. (TSX: IN) announced today that it has provided written notice to the Toronto Stock Exchange of its

Valeo Pharma (CSE: VPH) this morning announced that it will be conducting a private placement. The placement will look to

MustGrow Biologics (CSE: MGRO) this morning reported on results for the use of its mustard-based biopesticide within tobacco field trials.

Rakovina Therapeutics (TSXV: RKV) has received patents as of this morning. Granted by both the European and Canadian patent offices,